Form 0920-0978 FluSurv-NET Laboratory Survey 2022-2023 Season

Testing Facility Name:

Testing Facility ID (FluSurv-NET use only):

Name of person completing form:

Date:

FluSurv-NET Laboratory Survey 2022–2023 Season

Form Approved
OMB No. 0920-0978

Survey Introduction
Administer this survey to labs that serve FluSurv-NET hospitals. The questions in this survey refer to diagnostic testing ordered by healthcare
providers for routine clinical care of hospitalized and emergency department (ED) patients only. All questions relate to testing performed on-site
within the lab facility unless otherwise specified. If a FluSurv-NET hospital lab sends specimens to one or more labs (other than commercial or state
public health labs) for clinical influenza, please have each lab complete this survey.
• Do NOT administer this survey to commercial labs or to state public health labs
• Do NOT administer this survey to labs that are not affiliated with FluSurv-NET hospitals
• Do NOT include information on testing for the purposes of EIP influenza
• Do NOT include information on testing for outpatients
This survey should take 5-10 minutes to complete. Thank you for your time!

Question
1. What is the role of the person completing this survey?
Laboratory staff at testing facility

FluSurv-NET staff

2. Please select the choice which best describes the laboratory type: (select one)
Hospital (private/public/community) laboratory

County public health laboratory

Federal government (military, IHS, Veteran’s Affairs) hospital laboratory

Other (specify):

University/medical school hospital laboratory

Influenza
3. Does the laboratory perform diagnostic testing for influenza on-site?
Yes  Answer question 4

No  Skip to question 8

4. Does the laboratory perform rapid influenza antigen diagnostic test (rapid test, RIDT)?
Yes, pediatric patients only  Answer question 4a
Yes, adult patients only  Answer question 4a

No, we confirm RIDT tests performed elsewhere in the hospital
(such as ED)  Skip to question 5

Yes, pediatric and adult patients  Answer question 4a

No  Skip to question 5

4a. Select the kit name(s) (manufacturer) for the rapid influenza antigen diagnostic test(s) performed or planned to be used at the laboratory:
(Check all that apply)
(https://www.cdc.gov/flu/professionals/diagnosis/table-ridt.html)
Acucy Influenza A&B Test (Sekisui Diagnostics, LLC)

B
 ioSign® Flu A+B or OraSure QuickFlu Rapid A+B Test or Polymedco
Poly stat Flu A&B Test or LifeSign LLC Status Flu A&B (Princeton
BioMedtech Corp.)

BD Veritor™ System for Rapid Detection of Flu A+B (CLIA-waived),
(Becton Dickinson & Co.)
BD Veritor™ System for Rapid Detection of Flu A+B (Moderately Complex),
(Becton Dickinson & Co.)

OSOM Ultra Plus Flu A&B Test (Sekisui Diagnostics, LLC)

BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B (Becton
Dickinson & Co.)

SARS-CoV-2 & Flu A/B Rapid Antigen Test (Roche)

Binax NOW® Influenza A&B Card 2 (Abbott)

Sofia® Analyzer and Influenza A+B FIA (Quidel Corp.)

™

QuickVue® Influenza A+B Test (Quidel Corp.)
Sofia® Analyzer and Influenza A+B FIA (CLIA-waived) (Quidel Corp.)
XPECT™ Influenza A/B (Remel Inc./Thermo Fisher Scientific)
Other, specify:

5. Does the laboratory perform molecular assays (including rapid molecular, RT-PCR, RVPs) for influenza?
Yes  Answer questions 5a-5c

No  Skip to question 6

Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering
and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for
reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30329; ATTN: PRA (0920-0978).
CS 332626-A

7/20/2022

Page 1 of 3

5a. Select kit name(s) (manufacturer) for all molecular assays performed or planned to be used at the laboratory: (Check all that apply)
(https://www.cdc.gov/flu/professionals/diagnosis/table-nucleic-acid-detection.html) Multiplex Assays Authorized for Simultaneous Detection
of Influenza Viruses and SARS-CoV-2 by FDA: (https://www.cdc.gov/flu/professionals/diagnosis/table-flu-covid19-detection.html)
ID Now™ Influenza A&B (CLIA Waived), (Abbott)†
Accula Flu A/Flu B (Mesa Biotech, Inc.)†
Alinity M Resp-4 Plex Assay (Abbott)‡
Aptima SARS-CoV-2/Flu/A/B‡
ARIES® Flu A/B & RSV Assay, (Luminex)
BioCode Respiratory Pathogen Panel, (Applied BioCode Inc)*
BioFire Pneumonia Panel (Biomerieux)
BioFire Pneumonia plus Panel (Biomerieux)
BioFire Respiratory Panel 2.1 (RP2.1) (Biomerieux)*‡
BioFire Respiratory Panel 2.1-EZ (RP2.1-EZ) (Biomerieux)*‡
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza B Lineage Genotyping Kit), (CDC Influenza Division)
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza A Subtyping Kit), (CDC Influenza Division)
CDC Influenza A/H5 (Asian Lineage) Virus Real-Time RT-PCR Primer and
Probe Set, (CDC Influenza Division)
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza A/B Typing Kit), (CDC Influenza Division)
CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
(CDC Influenza Division)‡
Cobas Liat Influenza A/B, (Roche Diagnostics)†
Cobas Liat Influenza A/B & RSV, (Roche Diagnostics)†
Cobas SARS-CoV-2 & Influenza A/B (Roche Diagnostics)‡
Cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test, (Roche Diagnostics)
ePlex Respiratory Pathogen Panel (GenMark Diagnostics)*†‡
ePlex Respiratory Pathogen Panel 2, (Genmark Diagnostics)*‡
eSensor® Respiratory Viral Panel (RVP), (GenMark Diagnostics)*

FluChip-8G Influenza A+B Assay, (InDevR)*
Idylla Respiratory IFV-RSV Panel, (Biocartis)*
IMDx Flu A/B and RSV for Abbott m2000, (IMDx)
Lyra Influenza A+B Assay, (Quidel)
Nx-TAG Respiratory Pathogen Panel, (Luminex Molecular Diagnostics Inc)*
Panther Fusion® Flu A/B RSV, (Assay Hologic)
Prodesse PROFLU™, (GenProbe/Hologic)
Prodesse ProFAST™, (GenProbe/Hologic)*
QIAstat-Dx Respiratory SARS-CoV-2 Panel (QIAGEN)*‡
Quest Diagnostics RC COVID-19 +Flu RT-PCR, (Quest Diagnostics)‡
Silaris Infuenza A & Btg, (Sekisui Diagnostic)†
Sofia 2 Flu + SARS Antigen FIA, (Quidel) †‡
Solana Influenza A+B Assay, (Quidel)
Simplexa™ Flu A/B & RSV, (Focus Diagnostics, 3M)
Simplexa™ Flu A/B & RSV Direct, (Focus Diagnostics, 3M)
Simplexa™ Influenza A H1N1 (2009), (Focus Diagnostics, 3M)
Simplexa™ Flu A/B & RSV Gen II (Diasorin)*
Verigene® Respiratory Pathogen Nucleic Acid Test (RP Flex), (Luminex)*
Xpert Xpress COV-2/Flu/RSV plus†‡
Xpert Xpress Flu Assay, (Cepheid)†
Xpert Xpress Flu/RSV Assay, (Cepheid) †
Xpert Xpress SARS-CoV-2/Flu/RSV, (Cepheid)†‡
x-TAG® Respiratory Viral Panel Fast (RVP FAST),
(Luminex Molecular Diagnostics Inc)*
In-house developed PCR assay
Other, specify:
= Rapid Molecular

†

*= can detect subtype

‡=Multiplex for influenza/SARS-CoV-2

5b. If more than one kit is selected above, please select the one kit that is (or will be) used most frequently for molecular assay at the laboratory
during the current influenza season:
ID Now™ Influenza A&B (CLIA Waived), (Abbott)†
Accula Flu A/Flu B (Mesa Biotech, Inc.)†
Alinity M Resp-4 Plex Assay (Abbott)‡
Aptima SARS-CoV-2/Flu/A/B‡
ARIES® Flu A/B & RSV Assay, (Luminex)
BioCode Respiratory Pathogen Panel, (Applied BioCode Inc)*
BioFire Pneumonia Panel (Biomerieux)
BioFire Pneumonia plus Panel (Biomerieux)
BioFire Respiratory Panel 2.1 (RP2.1) (Biomerieux)*‡
BioFire Respiratory Panel 2.1-EZ (RP2.1-EZ) (Biomerieux)*‡
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza B Lineage Genotyping Kit), (CDC Influenza Division)
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza A Subtyping Kit), (CDC Influenza Division)
CDC Influenza A/H5 (Asian Lineage) Virus Real-Time RT-PCR Primer and
Probe Set, (CDC Influenza Division)
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza A/B Typing Kit), (CDC Influenza Division)
CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
(CDC Influenza Division)‡
Cobas Liat Influenza A/B, (Roche Diagnostics)†
Cobas Liat Influenza A/B & RSV, (Roche Diagnostics)†
Cobas SARS-CoV-2 & Influenza A/B (Roche Diagnostics)‡
Cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test, (Roche Diagnostics)
ePlex Respiratory Pathogen Panel (GenMark Diagnostics)*†‡
ePlex Respiratory Pathogen Panel 2, (Genmark Diagnostics)*‡
eSensor® Respiratory Viral Panel (RVP), (GenMark Diagnostics)*

FluChip-8G Influenza A+B Assay, (InDevR)*
Idylla Respiratory IFV-RSV Panel, (Biocartis)*
IMDx Flu A/B and RSV for Abbott m2000, (IMDx)
Lyra Influenza A+B Assay, (Quidel)
Nx-TAG Respiratory Pathogen Panel, (Luminex Molecular Diagnostics Inc)*
Panther Fusion® Flu A/B RSV, (Assay Hologic)
Prodesse PROFLU™, (GenProbe/Hologic)
Prodesse ProFAST™, (GenProbe/Hologic)*
QIAstat-Dx Respiratory SARS-CoV-2 Panel (QIAGEN)*‡
Quest Diagnostics RC COVID-19 +Flu RT-PCR, (Quest Diagnostics)‡
Silaris Infuenza A & Btg, (Sekisui Diagnostic)†
Sofia 2 Flu + SARS Antigen FIA, (Quidel) †‡
Solana Influenza A+B Assay, (Quidel)
Simplexa™ Flu A/B & RSV, (Focus Diagnostics, 3M)
Simplexa™ Flu A/B & RSV Direct, (Focus Diagnostics, 3M)
Simplexa™ Influenza A H1N1 (2009), (Focus Diagnostics, 3M)
Simplexa™ Flu A/B & RSV Gen II (Diasorin)*
Verigene® Respiratory Pathogen Nucleic Acid Test (RP Flex), (Luminex)*
Xpert Xpress COV-2/Flu/RSV plus†‡
Xpert Xpress Flu Assay, (Cepheid)†
Xpert Xpress Flu/RSV Assay, (Cepheid) †
Xpert Xpress SARS-CoV-2/Flu/RSV, (Cepheid)†‡
x-TAG® Respiratory Viral Panel Fast (RVP FAST),
(Luminex Molecular Diagnostics Inc)*
In-house developed PCR assay
Other, specify:
= Rapid Molecular

†

FluSurv-NET Laboratory Survey 2022–2023 Season

Page 2 of 3

*= can detect subtype

‡=Multiplex for influenza/SARS-CoV-2

5c. Does the laboratory perform influenza A subtyping?
Yes

No

6a. Which influenza test method does the laboratory perform most frequently for pediatric patients (aged 0-17 years)? (Select one)
Rapid influenza antigen diagnostic test (rapid test, RIDT)

Standard Molecular assay (e.g. RT-PCR, NAAT) – singleplex (influenza only)

Rapid Molecular assay (e.g. RT-PCR, NAAT) – singleplex (influenza only)

Standard Molecular assay (e.g. RT-PCR, NAAT) – dualplex/multiplex/
respiratory viral panel (RVP)

Rapid Molecular assay (e.g. RT-PCR, NAAT) - dualplex/multiplex†

Not applicable (no pediatric testing)
=Rapid Molecular assays which provide results in <30 minutes, include, but are not limited to the following kits: IDNow™, Accula Flu A/Flu B,Cobas® Liat Influenza A/B Assay, Cobas®
Liat Influenza A/B & RSV Assay, Silaris Influenza A&B, Sofia 2 Flu + SARS Antigen FIA, Xpert Xpress

†

6b. Which influenza test method does the laboratory perform most frequently for adult patients (aged ≥18 years)? (Select one)
Rapid influenza antigen diagnostic test (rapid test, RIDT)

Standard Molecular assay (e.g. RT-PCR, NAAT) – singleplex (influenza only)

Rapid Molecular assay (e.g. RT-PCR, NAAT) – singleplex (influenza only)

Standard Molecular assay (e.g. RT-PCR, NAAT) – dualplex/multiplex/
respiratory viral panel (RVP)

Rapid Molecular assay (e.g. RT-PCR, NAAT) - dualplex/multiplex†

Not applicable (no pediatric testing)
=Rapid Molecular assays which provide results in <30 minutes, include, but are not limited to the following kits: IDNow™, Accula Flu A/Flu B,Cobas® Liat Influenza A/B Assay, Cobas®
Liat Influenza A/B & RSV Assay, Silaris Influenza A&B, Sofia 2 Flu + SARS Antigen FIA, Xpert Xpress

†

7. Based on tests that were performed during the 2021-2022 influenza season, approximately what percent of the time are each of these test types
used to test for flu overall? (Answers should add to 100%)
% Other test type
% Rapid influenza antigen diagnostic test (rapid test, RIDT)
% Rapid Molecular assay (e.g. RT-PCR, NAAT) - singleplex (influenza only)†
% Rapid Molecular assay (e.g. RT-PCR - dualplex/multiplex†
% Standard Molecular assay (e.g. RT-PCR, NAAT) – singleplex (influenza only)
% Standard Molecular assay (e.g. RT-PCR, NAAT) – dualplex/multiplex/respiratory viral panel (RVP)
=Rapid Molecular assays which provide results in <30 minutes, include, but are not limited to the following kits: IDNow™, Accula Flu A/Flu B,Cobas® Liat Influenza A/B Assay, Cobas®
Liat Influenza A/B & RSV Assay, Silaris Influenza A&B, Sofia 2 Flu + SARS Antigen FIA, Xpert Xpress

†

8. Does the lab send specimens to other labs for clinical testing of influenza? (optional)
Yes  Answer question 9a

No  Skip to question 10

8a. Select all that apply: (optional)
Commercial lab(s): List names of all labs:
Public Health lab(s): List names of all labs:
Other lab(s): List names of all labs:
9. Laboratory comments:

FluSurv-NET site use only
10. List all in - catchment FluSurv-NET hospital IDs (hosp_TX) associated with this testing facility.
Hospital ID 1 (Required):

Hospital ID 6:

Hospital ID 2:

Hospital ID 7:

Hospital ID 3:

Hospital ID 8:

Hospital ID 4:

Hospital ID 9:

Hospital ID 5:

Hospital ID 10:

CS 332626-A

7/20/2022

Page 3 of 3

(Do not include names - CDC receives this info)